Insights on Health Care

Health Care Partner Annie Lee will present at the California Association Medical Staff Services’ (CAMSS) 53rd Annual Educational Forum in San Diego, California, on May 21, 2024.

Disputes between 340B Drug Pricing Program-covered entities and the drug manufacturers required to sell outpatient drugs to those entities at discounted prices will be governed by an alternative dispute resolution (ADR) process under a Final Rule published on April 19, by the US Department of Health and Human Services’ Health Resources and Services Administration (HRSA).

On April 23, the US Department of Labor (DOL) released a final rule significantly expanding the definition of who qualifies as a fiduciary under the Employee Retirement Income Security Act (ERISA) (the Retirement Security Rule or Final Rule).

On April 25, the US Court of Appeals for the Third Circuit issued its precedential opinion in Mallinckrodt v. Sanofi-Aventis, Case No. 23-1111.

Last week, the US Court of Appeals for the Fourth Circuit issued a decision holding that state health care plans in North Carolina and West Virginia must cover gender-affirming surgeries.

On February 14, the US Department of Health and Human Services (HHS) Office for Civil Rights (OCR) issued its annual reports to Congress detailing its actions to enforce the privacy, security, and breach notification requirements under the Health Insurance Portability and Accountability Act (HIPAA).

In a win for plaintiffs, the US Court of Appeals for the Ninth Circuit recently reversed a district court’s dismissal of key claims in the case of Ryan S. v. UnitedHealth Group, Inc.

Health Care Partner Annie Lee will present at the California Society for Healthcare Attorneys’ (CSHA) 2024 Annual Meeting and Spring Seminar in Olympic Valley, CA, on May 3, 2024.

With 2024 well underway, this article highlights some of the pressing legal issues impacting the long term care and senior housing industry this year, including trends affecting the industry and emerging issues industry participants likely will face throughout the rest of 2024 and beyond.

With the end of the first quarter of 2024, we highlight five developments, changes, or challenges that health systems, hospitals, nursing homes, clinics, physician practices, health insurers, and other health care providers, companies, and investors may face when entering into health care transactions in the US market.

The National Institute of Mental Health reported that 16.32% of youth (aged 12-17) in the District of Columbia (DC) experience at least one major depressive episode (MDE).

On March 5, the Federal Trade Commission (FTC), the US Department of Justice (DOJ) Antitrust Division, and the US Department of Health and Human Services (HHS) launched a cross-government inquiry into the role private equity firms, other alternative asset managers, health systems, and private payers play in health care transactions.

Change Healthcare, an affiliate of Optum and UnitedHealth Group, processes more than 15 billion health care transactions annually and touches one of every three patient records.

On March 7, Deputy Attorney General Lisa Monaco delivered the keynote remarks at the American Bar Association’s (ABA) 39th National Institute on White Collar Crime.

ArentFox Schiff is proud to announce the firm has been recognized by the 2024 JD Supra Readers’ Choice Awards, which acknowledges top authors and firms for the visibility and engagement their thought leadership earned among readers in select subjects during the past year.

Health Care Practice Leader Douglas Grimm was quoted by Healthcare Risk Management discussing the importance of adhering to telehealth best practices, Health Insurance Portability and Accountability Act (HIPAA) compliance, the necessity of educating patients regarding the technology, and the inevitability of lapses as telehealth technologies continue to evolve in sophistication and popularity.

Headlines that Matter for Companies and Executives in Regulated Industries

Partner and Reproductive Health Task Force Co-Leader Jill Steinberg was quoted on the Biden Administration’s limited ability to protect access in vitro fertilization (IVF), despite signaling its commitment to supporting legislation.

Earlier this month, the US District Court for the District of Oregon issued a declaratory judgment invalidating a key component of the Oregon Drug Price Transparency Program.

As we predicted at the end of the 117th Congress, 2023 was a year of progress for advocates of Pharmacy Benefit Manager (PBM) reform.

Health Care Partner Lowell Brown and Counsel Sarah Benator will present at The Institute for Medical Leadership’s Chief of Staff Boot Camp in Los Angeles, California, on February 23-25, 2024.

The top legal issues in 2024 for the life sciences field reflect the complex and changing legal landscape that the industry is navigating, encompassing drug pricing, regulatory challenges, and broader societal and governance concerns.

GPOs are adapting to ongoing industry hurdles by leveraging cutting-edge technologies and lessons learned from the pandemic, according to the Healthcare Group Purchasing Industry Initiative’s (HGPII) 18th Annual Report, released today.

Health Care Practice Leader Douglas A. Grimm was quoted by STAT News discussing the economic decisions of the Corvallis Clinic in Oregon, which is seeking a buyer due to severe financial difficulties, emphasizing the importance of transparency for community trust in such transactions.

On January 30, a federal jury found six people guilty of federal civil rights offenses arising from their participation in a blockade of a reproductive health care clinic in Mount Juliet, Tennessee.